OR WAIT null SECS
September 02, 2014
Experts from Baxter BioPharma Solutions provided the following commentary on trends in bio/pharmaceutical development outsourcing.
August 01, 2014
Representatives of contract service organizations that develop biologic-based drugs discussed technology trends such as high-throughput screening and single-use systems.
Representatives of contract service organizations that specialize in parenteral drug development and manufacturing describe the evolving trends.
Contract development and manufacturing organizations identify trends, challenges, and emerging technology and service needs for solid and semi-solid dosage forms.
July 16, 2014
Hovione will use Merrion's GIPET absorption-enhancing technology for solid-dosage drugs.
April 02, 2014
Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.
February 02, 2014
CMOs may find opportunities in alternative expression services.
February 01, 2014
Traditional project decision-making is compared with a QbD approach.
Increased competition from CMOs in Asia means that Western CMOs need to understand fundamental changes in the market.
A changing biopharmaceutical industry is going beyond typically outsourced activities and is using CMOs for more challenging processes. Review the top 10 outsourcing trends.
